Pandey Divya, Sharma Ritu, Sharma Shakti, Salhan Sudha
Assistant Professor, Department of Obstetrics and Gynaecology, VMMC and Safdarjung Hospital, Delhi, India.
Assistant Professor, Department of Obstetrics and Gynaecology, NDMC Medical College and Hindu Rao Hospital, Delhi, India.
J Clin Diagn Res. 2017 Mar;11(3):QD08-QD10. doi: 10.7860/JCDR/2017/21017.9506. Epub 2017 Mar 1.
Carbohydrate antigen 19-9 (CA 19-9) is a tumour marker found to be elevated in some ovarian tumours. We share our experience with a 55-year-old postmenopausal lady with unusually high CA19-9 levels arising from a benign mucinous cystadenoma of the ovary. The levels returned to normal eight weeks following staging laparotomy and a total abdominal hysterectomy with bilateral salpingo-oopherectomy. This report shows rare and significant elevation of CA 19-9 levels with benign mucinous cystadenomas of the ovary thus showing that women with unusually elevated tumour markers may actually harbour benign disease. The tumour markers should not be used to predict the malignant status of a tumour.
糖类抗原19-9(CA 19-9)是一种肿瘤标志物,在某些卵巢肿瘤中发现其水平会升高。我们分享一位55岁绝经后女性的病例,她因卵巢良性黏液性囊腺瘤导致CA19-9水平异常升高。在分期剖腹探查术以及全腹子宫切除术加双侧输卵管卵巢切除术后八周,该指标水平恢复正常。本报告显示,卵巢良性黏液性囊腺瘤可出现罕见且显著的CA 19-9水平升高,这表明肿瘤标志物异常升高的女性实际上可能患有良性疾病。肿瘤标志物不应被用于预测肿瘤的恶性状态。